Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.590 +0.130 (+8.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript
INO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Inovio Pharmaceuticals Q1 Earnings
Shares of Inovio Pharmaceuticals (NASDAQ:INO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.85% over... 
Via Benzinga
Inovio's DNA COVID-19 Vaccine Candidate Triggers Immune Response In Pivotal Study
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced positive data from the Phase 2 segment of its Phase 2/3 INNOVATE trial in the U.S.,... 
Via Benzinga
Exposures COVID-19
20 Stocks Moving in Monday's Pre-Market Session
Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... 
Via Benzinga
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
Preview: Inovio Pharmaceuticals's Earnings
Inovio Pharmaceuticals (NASDAQ:INO) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday morning, 58 companies hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was Lufax Holding (NYSE:LU).... 
Via Benzinga
Cramer Weighs In On Coinbase, Kellogg And More
Jim Cramer said on CNBC's "Mad Money Lightning Round" that he has always felt that Ocugen Inc (NASDAQ: OCGN) is a great spec, but it's a heavily shorted stock... 
Via Benzinga
Can Inovio Recover From Its Huge Setback?
It might be able to, although it won't be easy. 
Via The Motley Fool
Exposures COVID-19
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Is There Any Hope for Inovio?
Everything may depend on an early-stage program. 
Via The Motley Fool
Exposures COVID-19
50 Biggest Movers From Friday
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares surged 59.1% to close at $4.47 on Friday after the company said its electronics unit has won a contract for deep space... 
Via Benzinga
Market Briefing For Monday, Apr. 26
Nasdaq is perking up, primarily led by FANG types reporting next week (discounted). So, higher a bit near-term; then, risks. 
Via Talk Markets
Mid-Afternoon Market Update: Nasdaq Surges 1.5%; EDAP Shares Plunge
Toward the end of trading Friday, the Dow traded up 0.67% to 34,041.01 while the NASDAQ rose 1.54% to 14,031.45. The S&P also rose, gaining 1.16% to 4,182.83. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Skechers Jumps On Earnings Beat; Inovio Pharmaceuticals Shares Drop
Midway through trading Friday, the Dow traded up 0.52% to 33,992.56 while the NASDAQ rose 0.93% to 13,947.48. The S&P also rose, gaining 0.82% to 4,168.89. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
32 Stocks Moving In Friday's Mid-Day Session
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares climbed 24.7% to $3.50 after the company said its electronics unit has won a contract for deep space program. MicroVision,... 
Via Benzinga
Inovio Stock Collapses After U.S. Officials Pull Funding For Covid Vaccine Test
Inovio said Friday the Department of Defense pulled its funding for final-phase testing of the company's Covid vaccine, prompting INO stock to collapse. 
Via Investor's Business Daily
Why Inovio Stock Is Crashing Today
The biotech just lost funding for the late-stage study of its COVID-19 vaccine candidate. 
Via The Motley Fool
Exposures COVID-19
Stocks That Hit 52-Week Lows On Friday
During the morning session on Friday, 6 stocks hit new 52-week lows. Facts of Interest: The company with the largest market cap to set a new 52-week low was Quidel... 
Via Benzinga
Mid-Morning Market Update: Markets Rise; Honeywell Beats Q1 Estimates
Following the market opening Friday, the Dow traded up 0.11% to 33,852.74 while the NASDAQ rose 0.82% to 13,932.03. The S&P also rose, gaining 0.47% to 4,154.53. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Inovio Stock Slumps After Plans To Exclude US For COVID-19 Vaccine Candidate's Global Trial
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares dived in the premarket in reaction to the company's plans for a predominantly ex-U.S. Phase 3 trial for... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205.... 
Via Benzinga
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio
It's all about the ultimate coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
Why PPD, Immunic, Inovio and CureVac Shares Are Higher Today
PPD, Inc. (NASDAQ: PPD), Immunic, Inc. (NASDAQ: IMUX), Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and CureVac N.V. (NASDAQ: CVAC) are among the healthcare movers on Thursday. PPD... 
Via Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Apr. 15, 2021: DELL, AEO, GSK, UNH, INO
Today's 5 Stock Ideas: Dell Technologies (DELL) - Shares were up about 8% Thursday morning after the company announced the planned spin-off of VMware. American... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Assertio Holdings (NASDAQ:ASRT) stock increased by 19.41% to $0.62 during Thursday's pre-market session. The company's market cap stands at $107.3 million... 
Via Benzinga
INOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO
From Kahn Swick & Foti, LLC
Via Business Wire
Cramer Gives His Opinion On Verizon, Boeing And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he's going to put Inovio Pharmaceuticals Inc (NASDAQ: INO) on hold. A lot of promises, but not a lot of... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback